Oxford Nanopore Technologies PLC

ONT

Company Profile

  • Business description

    Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.

  • Contact

    Edmund Halley Road
    Gosling Building, Oxford Science Park
    OxfordOxfordshireOX4 4DQ
    GBR

    T: +44 8450347900

    https://www.nanoporetech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,281

Stocks News & Analysis

stocks

Ask the analyst: Can this big Covid loser scale its former heights?

Corporate Travel Management saw its profits fall through the floor during the pandemic. Our analyst Brian Han answers a reader question on what might be next.
stocks

Our view of BHP after reporting sales volumes

First half results largely met our expectations.
stocks

The fight for Insignia continues

Numerous acquisition proposals vindicate Insignia's improved earnings momentum.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change

Market Movers